GENTIVA HEALTHCARE CORPORATION, doing business as Heritage Home Health, Appellant v. Kathleen SEBELIUS, Secretary, U.S. Department of Health and Human Services, Appellee.
No. 12-5179.
United States Court of Appeals, District of Columbia Circuit.
Argued May 3, 2013. Decided July 23, 2013.
723 F.3d 292
Adam C. Jed, Attorney, U.S. Department of Justice, argued the cause for appellee. With him on the brief were Stuart F. Delery, Principal Deputy Assistant Attorney General, Ronald C. Machen Jr., U.S. Attorney, and Mark B. Stern, Attorney.
Before: GARLAND, Chief Judge, BROWN, Circuit Judge, and SENTELLE, Senior Circuit Judge.
Opinion for the Court filed by Chief Judge GARLAND.
Gentiva Healthcare Corporation is а provider of home health-care services. Gentiva contends that the Secretary of Health and Human Services violated the Medicare statute by delegating to an outside contractor the authority to determine whether Gentiva‘s Medicare reimbursement claims exhibited а “sustained or high level of payment error.”
I
The Medicare program is administered by the Secretary of the Department of Health and Human Services (HHS).
At the core of this appeal are amendments to the Medicare Integrity Program that Congress enacted in 2003. See
Cahaba procеeded to draw a sample of 30 claims. Of these, it initially determined that 26 claims—nearly 87% of the sample—were overpaid. Extrapolating this error rate over all of the relevant claims, Cahaba determined that Medicare had overpaid Gentiva by $4,242,452.10. After Gentiva successfully challenged Cahaba‘s overpayment determination as to ten of the claims in the sample, Cahaba revised its extrapolation and calculated a lower overpayment principal of $2,112,778.00. See ALJ Decision at 1-2.
Before an HHS Administrative Law Judge (ALJ), Gentiva challenged Cahaba‘s overpayment determination as to ten more claims in the sample. Gentiva also charged that Cahaba‘s sampling and extrapolation method was itself invalid. The ALJ agreed with Gentiva that the ten identified claims had not been overpaid and directed that the extrapolation bе recalculated accordingly. But the ALJ upheld as valid the statistical sampling and extrapolation methodology that Cahaba used. See ALJ Decision at 20-21.
Gentiva appealed the ALJ‘s approval of Cahaba‘s use of extrapolation to the Medicare Appеals Council of HHS’ Departmental Appeals Board. Gentiva “advance[d] only one contention” before the Appeals Council: that
because Congress used the terminology ‘a [M]edicare cоntractor’ and ‘the Secretary’ in the same sentence, it intended that the Secretary herself make a determination of a sustained or high level of payment error and, therefore, the Secretary may not assign or delegate this function to a contractor.
Gentiva challenged the Medicare Appeals Council‘s decision in district court. See
Applying the framework of Chevron U.S.A. Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837, 104 S. Ct. 2778, 81 L. Ed. 2d 694 (1984), the court first concluded that, “[i]n the absence of any explicit indication that the § 1395ddd(f)(3) ‘sustained or high level of payment error’ determination was intended as an exception to” the Secretary‘s “broad power” to delegate to contractors undеr
II
On appeal, Gentiva challenges the district court‘s decision to defer to the Sеcretary‘s construction of
A
First, we agree with the district court that review of the Secretary‘s construction of
Gentiva argues that
Gentiva is right that delegations to non-governmental entities are different and may even be “assumed to be improper absent an affirmative showing of congressional authorization.” U.S. Telecom Ass‘n, 359 F.3d at 565. Cf. Ass‘n of Am. R.Rs. v. U.S. Dep‘t of Transp., 721 F.3d 666, 671 (D.C. Cir. 2013) (noting that, although a statute may not “empower[] private parties to wield regulatory authority[,] [s]uch entities may ... help a government agency make its regulatory decisions“). But here, Congress has provided such an affirmative showing in
As we discuss in Part II.B below, Congress has insulated from judicial review the merits of the Secretary‘s “sustained or high level of payment error” determination. This fact does not, however, alter our conclusion that the Secretary may delegate that determination to a contractor. The determination that there was a sustained or high level of payment error is only a screening mechanism employed to deсide whether extrapolation may be used to calculate a final overpayment amount. Providers like Gentiva can still challenge—at the agency level and in court—both the final overpayment calculation and the extrapolation methodology that was used to calculate it. See Oral Arg. Recording at 21:42-23:11 (acknowledgment by HHS’ counsel). Indeed, Gentiva successfully overturned every individual overpayment claim that it challenged before the Medicare Appeals Council. In so doing, it succeeded in cutting the contractor‘s overpayment сalculation in half, from a little more than $4 million to a little more than $2 million, without overturning the “sustained or high level of payment error” determination. See ALJ Decision at 1. Given that this significant level of review of final overpayment calculations remains available, it is not unreasonable for the Secretary to believe that Congress intended to permit contractors to make unreviewable determinations at the screening level.1
B
We also agree with the district court that
III
For the foregoing reasons, the judgment of the district court is
Affirmed.
